FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: North Carolina, a state with a growing biotechnology sector and numerous pharmaceutical manufacturing facilities, could see an impact on its life sciences industry and workforce if this mRNA flu vaccine receives FDA approval.

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.